REVIEW
Add like
Add dislike
Add to saved papers

[Perilymphatic fistula. Diagnostic and therapeutic difficulties].

The symptoms and signs of perilymphatic fistulae (PLF) are very varied and frequently misleading. The operative demonstration of a perilymph leak is not always obvious and the therapeutic results are sometimes disappointing. The study of 26 cases demonstrates certain concepts concerning the diagnostic and therapeutic difficulties. Any atypical cochleovestibular symptoms, particularly occurring in a traumatic context, should suggest the possibility of PLF. Exploratory surgery must be performed according to a rigorous protocol in order to demonstrate the fistula. Search for a fenestra ovalis sign due to pressure on the membrane of the fenestra rotunda may help to reveal a lesion of the annular ligament. Simple filling of the breach is not always effective, especially at the level of the stapes. Stapedectomy frequently constitutes the best solution for fistulae of the fenestra ovalis.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app